期刊文献+

渗出型年龄相关性黄斑变性的形态学及视功能的研究 被引量:1

The relation between configuration and visual function of macular region on exudative age-related macular degeneration
原文传递
导出
摘要 通过将渗出型年龄相关性黄斑变性(age-relatedmaculardegeneration,AMD)患者黄斑区OCT形态学检查及视觉电生理视功能检查相结合,探讨渗出型AMD的形态学改变与视功能改变之间的相互关系。方法选取初次诊断为年龄相关性渗出型AMD的患者渗出组20例(30只眼)以及同年龄段正常对照组15名(30只眼),根据眼底及荧光造影检查将渗出组仅发生玻璃膜疣和脉络膜新生血管膜(CNV)的12只眼归为早期渗出组,并发视网膜下出血及渗出的18只眼归为渗出期组。对三组病人进行黄斑中心凹OCT检查及眼电生理检查。采用单因素方差分析检查结果。结果(1)黄斑中心凹水平及垂直神经上皮层厚度:早期渗出组较正常组明显增厚(P〈0.05);渗出期组较正常组和早期渗出组明显增厚(P〈0.05)。(2)眼电生理检查结果:暗适应ERG,OPS振荡电位以及P—VEP的检查结果表明,早期渗出组已出现了明显的视功能损害;渗出期组的视功能受损较早期渗出组严重。结论渗出型AMD患者视功能的改变合并有视网膜神经上皮层的变厚,渗出期患者的黄斑区形态以及视网膜功能的改变比渗出早期更严重。 Objective To investigate the relation between configuration and visual function ofmacular region on exudative age-related maeular degeneration (AMD). Methods OCT and visual electrophysiological examination were used in 30 eyes of 15 healthy volunteers and 30 eyes of 20 exudative AMD patients. Patients with exudative AMD were divided into pre-exudative group and exudative group .Results 1.The results of OCT showed that, the thickness of retinal neurepithelium layer (in macular region) in the pre-exudarive group was significantly thicker than that in the normal group (P〈0.05) ; and it was also significantly thicker in the exudative group than that in the other groups (P〈0.05).2.The results of visual electrophysiologieal examination revealed that visual function injury happened in the pre-exudative group, and it was more severe in the exudative AMD group than that in the pre-exudative group.Conclutions In exudative AMD, we found the damage of visual function is accompanied by the change of retinal neurepithelium layer' s thickness in macular region.The functional damage of vision and the retinal neurepithelium layer' s swelling in the exudative group are more serious than that in the pre-exudative group.
出处 《中国实用眼科杂志》 CSCD 北大核心 2010年第4期327-330,共4页 Chinese Journal of Practical Ophthalmology
关键词 渗出型年龄相关性黄斑变性 光学相干断层扫描 眼电生理检查 Exudative age-related macular degeneration Visual coherence tomography Visual electrophysiological examination
  • 相关文献

参考文献6

二级参考文献23

  • 1姜荔,马志中.渗出型老年性黄斑变性患者继发黄斑囊样水肿分析[J].中华眼底病杂志,2004,20(5):299-302. 被引量:2
  • 2周咏东,周天球,范红娟.经瞳温热疗法治疗湿性年龄相关黄斑变性的疗效观察[J].国际眼科杂志,2005,5(5):961-963. 被引量:13
  • 3曹东,贺翔鸽,刘莛,孙强.光学相干断层成像术检测5~18岁国人正常眼视网膜神经纤维层厚度[J].国际眼科杂志,2006,6(1):97-101. 被引量:14
  • 4汤洋,唐罗生.正常国人的光学相干断层扫描测量[J].国际眼科杂志,2006,6(5):1087-1089. 被引量:6
  • 5中华医学会眼科学会眼底病学组.老年性黄斑变性临床诊断标准[J].眼底病,1987,3:3-3.
  • 6中华医学会眼科学会眼底病学组.老年黄斑变性临床诊断标准[J].眼底病,1987,3:3-3.
  • 7[2]Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration[J]. Arch Ophthalmol 1999;117∶1161-1173.
  • 8[3]Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin[J]. Arch Ophthalmol 1999;117∶1329-1345.
  • 9[4]Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study[J]. Arch Ophthalmol 1999;117∶1177-1187.
  • 10Schuman JS,Puliafito CA,Fujimoto JG.Optical coherence tomography of ocular diseases.2nd ed.New Jersoy:Slack Inc,2004.243-311.

共引文献42

同被引文献39

  • 1邹海东,张晳,许迅,汪枫桦,张世杰.上海市静安区曹家渡街道年龄相关性黄斑变性的患病率调查[J].中华眼科杂志,2005,4(1):15-19. 被引量:108
  • 2Samantha S. Dandekar,Sharon A. Jenkins,Tunde Peto,Hendrik P. N.Scholl,Kulwant S. Sehmi,Fred W. Fitzke,Alan C. Bird,Andrew R. Webster,李越(译),惠延年(校).年龄相关性黄斑变性产生的脉络膜新生血管自发荧光成像[J].美国医学会眼科杂志(中文版),2006,18(3):139-145. 被引量:1
  • 3American Academy of Ophthalmology Retina Panel.Preferred Practice Pattern@Guidelindes:age-related macular degeneration EB/OL I.San Francisco,CA:Ameriean Academy of Ophthalmology (AAO),2008.
  • 4Schmidt-Erfurth UM,Richard G,Augustin A,et al.Guidance for the treatment of neovascuiar age-related macular degeneration.Acta Ophthalmol Scand,2007,85 (5):486-494.
  • 5Age-Related Eye Disease Study Research Group.A randomized,placebo-controlled,clinical trial of high-dose supplementation with vitamins C and E,beta carotene,and zinc for age-related macular degeneration and vision loss:AREDS report no 8.Arch Ophthalmol,2001,119(10):1417-1436.
  • 6Rattner A,Nathans J.Macular degeneration:recent advances and therapeutic opportunities.Nat Rev Neurosci,2006,7 (11):860-872.
  • 7Lu H,Lu Q,Gaddipati S.IKK2 Inhibition attenuates laser-induced choroidal neovascularization.PLoS One,2014,9 (1):e87530.
  • 8Yoneyama S,Sakurada Y,Mabuchi F.Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related maculardegeneration.Graefes Arch Clin Exp Ophthalmol,2014,252(9):1435-1441.
  • 9Smith W,Assink J,Klein R,et al.Risk factors for age-related macular degeneration:pooled findings from three continents.Ophthalmology,2001,108(4):697-704.
  • 10The Eye Diseases Prevalence Research Group.Prevalence of agerelated macular degeneration in the United States.Arch Ophthalmol,2004,122(4):564-572.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部